Women's views and the impact of noninvasive prenatal testing on procedures in a managed care setting

Prenatal Diagnosis

Volumn 35, Issue 5, 2015, Pages 428-433

  Tiller, George E ^a   Kershberg, Hilary B ^a   Goff, John ^a   Coffeen, Christin ^b   Liao, Wayne ^b   Sehnert, Amy J ^b  

^a Southern California Permanente Medical Group   (United States)

^b Illumina ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMNIOCENTESIS; ANEUPLOIDY; ARTICLE; COMPARATIVE STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; GENETIC COUNSELING; GESTATIONAL AGE; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MANAGED CARE; MIDDLE AGED; NON INVASIVE PROCEDURE; NONINVASIVE PRENATAL TESTING; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; ADOLESCENT; ATTITUDE TO HEALTH; BLOOD; CHORION VILLUS SAMPLING; CHROMOSOME DISORDERS; COHORT ANALYSIS; DECISION MAKING; GENETIC SCREENING; HEALTH INSURANCE; PREGNANCY; QUESTIONNAIRE; UNITED STATES; UTILIZATION; YOUNG ADULT;

DNA;

ADOLESCENT; ADULT; AMNIOCENTESIS; ANEUPLOIDY; ATTITUDE TO HEALTH; CALIFORNIA; CHORIONIC VILLI SAMPLING; CHROMOSOME DISORDERS; COHORT STUDIES; DECISION MAKING; DNA; FEMALE; GENETIC TESTING; HUMANS; MANAGED CARE PROGRAMS; MIDDLE AGED; PREGNANCY; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84928414975     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4495     Document Type: Article

References (21)

1. ACOG. Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109:217-27.
2. Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353:2001-11.
3. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
4. Chiu RW, Akolekar R, Zheng YW, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401-9.
5. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011;204:205 e1- e11.
6. Sehnert AJ, Rhees B, Comstock D, et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011;57:1042-9.
7. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913-20.
8. Sparks AB, Wang ET, Struble CA, et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn 2012;32:3-9.
9. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14:296-305.
10. Futch T, Spinosa J, Bhatt S, et al. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn 2013;33:569-74.
11. Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207:137 e1-8.
12. Dan S, Wang W, Ren J, et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11, 105 pregnancies with mixed risk factors. Prenat Diagn 2012;32:1225-32.
13. American College of Obstetricians Gynecologists Committee on Genetics. Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012;120:1532-4.
14. Friel L, Czerwinski J, Singletary C. The impact of non-invasive prenatal testing on the practice of maternal fetal medicine. Am J Perinatol 2014;31(9):759-64.
15. Chetty S, Garabedian MJ, Norton ME. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenat Diagn 2013;33:542-6.
16. Platt LD, Janicki MB, Prosen T, et al. Impact of Noninvasive Prenatal Testing in Regionally Dispersed Medical Centers in the United States. Am J Obstet Gynecol 2014;211(4):368.e1-7.
17. Fairbrother G, Johnson S, Musci TJ, Song K. Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population. Prenat Diagn 2013;33:580-3.
18. Tischler R, Hudgins L, Blumenfeld YJ, et al. Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake. Prenat Diagn 2011;31:1292-9.
19. Hill M, Fisher J, Chitty LS, Morris S. Women's and health professionals' preferences for prenatal tests for Down syndrome: a discrete choice experiment to contrast noninvasive prenatal diagnosis with current invasive tests. Genet Med 2012;14:905-13.
20. Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014;370(9):799-808.
21. Sayres LC, Allyse M, Norton ME, Cho MK. Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation. Prenat Diagn 2011;31:1070-6.